Guanabenz

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H8Cl2N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GGD30112WC, chemically known as (2,6-dichlorophenyl)methylideneaminoiminomethanediamine but generally known as guanabenz, which bears US NIH Compound Identifier 3517. European Medicines Agency schedules Guanabenz in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07978MIG. GUANABENZ is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanabenz under HS 29280090 and SITC 51486. As of Q4 2014, GUANABENZ remains the US FDA Preferred Term for this commodity. Guanabenz bears US NLM identifiers UMLS ID C0018312 and NCI Concept Code C83740. SMILES: Clc1c(c(Cl)ccc1)/C=N/N=C(/N)N.